Kristen Harrington-Smith

Insider Reports History

Entity
Individual
Location
C/O Immunogen, Inc., 830 Winter Street, Waltham, MA
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Kristen Harrington-Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen Harrington-Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP & CHIEF COMMERCIAL OFFICER Restricted Stock Unit 50K $1.47M $29.40 Nov 15, 2022 Direct
ImmunoGen, Inc. SVP & CHIEF COMMERCIAL OFFICER Common Stock 25K $741K $29.64 Nov 15, 2022 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 Jun 13, 2024 Direct

Insider Reports Filed by Kristen Harrington-Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EFTR eFFECTOR Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 13, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 19, 2024 1 $0 4 Feb 21, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 22, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Jan 20, 2023 1 $0 4 Jan 24, 2023 Director
IMGN ImmunoGen, Inc. Nov 15, 2022 2 $0 4 Nov 18, 2022 SVP & CHIEF COMMERCIAL OFFICER
EFTR eFFECTOR Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 15, 2022 0 $0 3 Feb 17, 2022 Director
IMGN ImmunoGen, Inc. Nov 15, 2021 2 $2.56M 4 Nov 17, 2021 SVP & Chief Commercial Officer
IMGN ImmunoGen, Inc. Nov 15, 2021 0 $0 3 Nov 17, 2021 SVP & Chief Commercial Officer